Compliance Rate

Compliance Rate 33.33%
Compliant submissions 1
Incompliant submissions 2
Total trials 3

My Organizations' Clinical Trials

Showing 725 of 788 entries
View as:

Enhancing School-Based Violence Prevention

Phase: N/A Priority: Normal
NCT ID: NCT04087772 Org: User:
Start: 09/13/19 End: 06/30/25 Due: 06/30/26

High Volume Caudal Study

Phase: N/A Priority: Normal
NCT ID: NCT04263064 Org: User:
Start: 03/06/20 End: 08/19/22 Due: 08/19/23

Optimizing Tobacco Treatment Delivery for People Living With HIV

Phase: N/A Priority: Normal
NCT ID: NCT05019495 Org: User:
Start: 12/01/21 End: 02/28/27 Due: 02/28/28

Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00438685 Org: User:
Start: 10/31/04 End: 09/30/10 Due: 09/30/11

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

Phase: N/A Priority: Normal
NCT ID: NCT03624517 Org: User:
Start: 09/19/18 End: 12/01/24 Due: 12/01/25

Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00934024 Org: User:
Start: 04/30/09 End: 01/31/12 Due: 01/31/13

Globus Reflect Tether - HUD

Phase: N/A Priority: Normal
NCT ID: NCT06521814 Org: User:
Start: 11/01/25 End: 08/01/33 Due: 08/01/34

Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT

Phase: N/A Priority: Normal
NCT ID: NCT06925477 Org: User:
Start: 06/30/25 End: 04/30/26 Due: 04/30/27

Aneurysm Wall Histology Registry

Phase: N/A Priority: Normal
NCT ID: NCT01444664 Org: User:
Start: 06/30/10 End: 06/30/15 Due: 06/30/16

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Phase: N/A Priority: Normal
NCT ID: NCT05855369 Org: User:
Start: 10/02/23 End: 05/31/28 Due: 05/31/29

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

Phase: N/A Priority: Normal
NCT ID: NCT05816083 Org: User:
Start: 02/06/25 End: 02/28/26 Due: 02/28/27

Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments

Phase: N/A Priority: Normal
NCT ID: NCT05764759 Org: User:
Start: 03/07/23 End: 08/15/27 Due: 08/15/28

Hypothermia's Effect on Hepatitis B Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT05787899 Org: User:
Start: 05/18/23 End: 10/01/24 Due: 10/01/25

Novel Intervention Linking Public Housing With Primary Care to Prevent Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03526237 Org: User:
Start: 04/24/15 End: 07/01/17 Due: 07/01/18

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06162663 Org: User:
Start: 09/20/24 End: 11/01/26 Due: 11/01/27

Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With Combined Acoustic Vibration and Oscillating Expiratory Pressure

Phase: N/A Priority: Normal
NCT ID: NCT04404036 Org: User:
Start: 04/28/20 End: 04/25/23 Due: 04/25/24

Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

Phase: N/A Priority: Normal
NCT ID: NCT05070754 Org: User:
Start: 12/02/21 End: 12/31/22 Due: 12/31/23

Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass

Phase: N/A Priority: Normal
NCT ID: NCT01579513 Org: User:
Start: 06/30/12 End: 12/19/18 Due: 12/19/19

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01675661 Org: User:
Start: 01/31/14 End: 08/31/15 Due: 08/31/16

Peer Intervention to Link Overdose Survivors to Treatment (PILOT)

Phase: N/A Priority: Normal
NCT ID: NCT05123027 Org: User:
Start: 12/28/21 End: 02/08/24 Due: 02/08/25

Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches

Phase: N/A Priority: Normal
NCT ID: NCT06678789 Org: User:
Start: 02/14/25 End: 07/31/26 Due: 07/31/27

Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults

Phase: N/A Priority: Normal
NCT ID: NCT03039491 Org: User:
Start: 09/01/15 End: 03/30/20 Due: 03/30/21

Continuous Postoperative Pulse Oximetry in Patients Presenting for Total Hip and Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT01189565 Org: User:
Start: 03/31/10 End: - Due: -

Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03069937 Org: User:
Start: 03/01/17 End: 12/11/24 Due: 12/11/25

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00268450 Org: User:
Start: 09/21/05 End: 04/30/12 Due: 04/30/13